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cose (IFG) and 114 with impaired glucose tolerance (IGT), were included 
in the study and were followed-up 13.4 ± 2.2 months later. OGTT was 
performed in all participants. Anthropometric and laboratory parameters, 
blood pressure and body fat mass were assessed. 
Results: Progression rates from IFG and IGT to diabetes over 1 year were 
12.08 and 19.91 per 100 person-years, respectively. Baseline determi-
nants of progression from IFG to diabetes were found to be insulin resis-
tance (HOMA-IR) and systolic blood pressure, and from IGT to diabetes 
– overweight and obesity (BMI), waist circumference and HOMA-IR. 
The most significant predictors for the progression from IFG to diabetes 
were the increase in BMI, waist circumference, systolic blood pressure, 
total cholesterol and triglycerides; and for progression from IGT to dia-
betes – the changes in BMI, percentage of body fat, systolic and diastolic 
blood pressure.
Conclusion: Individuals with IFG or IGT have a rather high risk of de-
veloping diabetes within one year. The changes in body weight, waist 
circumference, body fat, total cholesterol, triglycerides, systolic and di-
astolic blood pressure are significant determinants of progression to di-
abetes, which implies for adequate measures for their control aiming at 
prevention of the disease.
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Introduction: The adipose tissue has become a central player in the 
pathogenesis of metabolic disease. The aim of this study was to evaluate 
whether preadipocytes from different depots, could change differently 
synthesis and secretion of insulin in beta-pancreatic cells.
Methods: We performed isolation, cultivation and differentiation of hu-
man preadipocytes using either abdominal subcutaneous or mesenteric 
adipose tissue obtained from bariatric interventions. The media from 
day 0,4,7,10,15 and 20 was added over PANC-1 beta-pancreatic cells 
(2X104cells) and the insulin and proinsulin levels were measured by ELI-
SA. We also used a transwell system in which the PANC-1 cells grown in 
the lower well of the 6-well culture plate were co-cultured for 24 hours 
with differentiated adipocytes in the transwell inserts (with 0.4µm po-
rous membrane). The leptin, adiponectin, insulin and proinsulin levels 
in co-cultured PANC-1 cells (media and cell lysates) were determined 
by ELISA as well. The experiments were done in duplicate and repeated 
four times.
Results: Intracellular proinsulin level was higher then in the media while 
insulin was lower in the cell lysates and these was maintained with adipo-
cytes differentiation. The expresion level of leptin increases steadily with 
the degree of differentiation only intracelular while levels of adiponec-
tin dit not differed. When the two types of cells were cocultured in the 
transwell system except for proinsulin all parameter did not differ from 
those obtained in experiment 1. Adiposse tissue origin does not influence 
neither synthesis nor secretion of insulin.
Conclusion: Our results suggest that the ratio between pro/antiinflama-
tory adipokines during adipocytes differentiation has an important rol in 
both production and secretion of insulin in beta-pancreatic cells.
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Introduction: Obesity is known to be associated with hypertension, one 
of the major causes of chronic kidney disease in adults. This study aims 
to evaluate the association between childhood obesity, cardiovascular and 
renal risk factors. 
Methods: A total of 104 consecutive obese children (IOTF, Cole et al., 
2000) investigated in 11.2012–11.2013 and aged 11.8 ± 3.6 (4–17.6 
years), without chronic diseases, were included (38.5% boys). Body 
weight, height, waist circumference (WC) and blood pressure (BP) were 
measured using standard procedures. Pubertal status was defined apply-
ing Tanner scale. Blood and urine samples were collected after a 12-hour 
overnight fasting. The presence of hypertension (systolic, diastolic or 
both) was defined according to NHBPEP (2004) as a measure above 90th 
percentile for age, sex and height.
Results: Above one third of the participants (41.6%) had elevated systol-
ic BP (83.8% pubertal, p < 0.001). Microalbuminuria (MA) was detect-
ed in 7.2% of the children (85.7% pubertal, p = 0.014). Systolic hyper-
tension and MA were simultaneously present in 3% of the children, all 
pubertal (mean age 15.69 ± 1.42 years) and with positive family history 
of hypertension. There were no significant correlations between positive 
MA and weight, BMI, WC. However, cardiovascular risk factors such 
as total cholesterol, HDL-cholesterol and hsCRP were significantly as-
sociated with MA in the pubertal group (p = 0.054, p = 0.038, p = 0.015 
respectively).
Conclusion: The current findings suggest development of kidney dys-
function in obese children with positive family history of hypertension 
after the initiation of puberty. Microalbuminuria might be a good marker 
to identify pubertal children with increased risk of endovascular damage.
T6 – Cancer
T6:PO.009
Effect of excess body adiposity on the expression 
of genes involved in early steps of mammary 
carcinogenesis on diet-induced obese female rats
Begoña Cabia, Ana Belén Crujeiras, María Amil, Marcos C. 
Carreira, Arturo Roca-Rivada, Cecilia Castelao, María Pardo, 
Luisa María Seoane, Felipe F. Casanueva
Dpt. Molecular and Cellular Endocrinology, University of Santiago de 
Compostela (USC) and Instituto de Investigación Sanitaria de Santiago de 
Compostela (IDIS), Spain. CIBER de Fisiopatología, Obesidad y Nutrición 
(CIBERobn), Instituto de Salud Carlos III
Introduction: Obesity is increasing worldwide and is associated with 
higher risk for some cancers. However, the mechanisms underlying this 
association are unclear. Because the obesity microenvironment could pro-
mote the onset of carcinogenesis, the aim of this study was to evaluate the 
association between excess body adiposity and the expression of genes 
related to the activation of early steps of tumor promotion on the mam-
mary gland. 
Methods: Three weeks-old female Sprague-Dawley rats were fed a high 
fat diet (DIO: 60% Kcal/g fat, n = 14) or standard chow (LEAN: 3% 
Kcal/g fat, n = 15) for 10 weeks. Body weight and food intake were mea-
sured weekly. After sacrifice, retroperitoneal fat tissue was weighed and 
mammary tissue was extracted for qRT-PCR analysis. Genes associated 
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with cell proliferation (Survivin/BIRC5 and MYC), DNA repair (TP53), 
and antioxidant protection (GSTM2, ALDH3A1) were quantified. 
Results: The DIO group showed a body weight 14.1% higher than LEAN 
group (p < 0.001). These differences were reflected on higher retroperi-
toneal fat content on DIO (3.22 ± 0.89g) vs. LEAN group (2.33 ± 0.52g; 
p = 0.012). Interestingly, DIO rats showed a higher gene expression 
for Survivin (∆68.2%), MYC (∆50.1%), TP53 (∆40.5%), ALDH3A1 
(∆74.1%), and GSTM2 (∆25.7%) with respect to LEAN group. 
Conclusion: These data show that obesity is associated with changes 
potentially involved in early steps of tumor promotion, as shown by an 
increase in cellular proliferation and DNA damage related genes, even 
before detecting histological changes on the mammary tissue of obese 
female individuals. Further studies are needed to elucidate weather reduc-
ing body weight might be a therapeutic strategy to prevent this process.
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Introduction: We have studied two hypotheses for the association be-
tween obesity and intestinal tumorigenesis.
Methods: These experiments were done in double mutant F1 offspring 
from intercrossing of C57BL/6J-ApcMin (adenomatous polyposis co-
li-multiple intestinal neoplasia)/+ mouse, which develops spontaneous 
intestinal tumors, and C57BL/6J-Lepob (leptin-obese)/+ mouse, which 
develops obesity, on 10% or 45% fat diet.
Results: Terminal body weight (bw) and number of small intestinal 
tumors were significantly increased in Min/+,ob/ob compared with 
Min/+,ob/+ and Min/+,+/+ mice. In these mice given a 45% fat diet from 
weaning to termination at 11 weeks, terminal bw and number of small 
intestinal tumors were increased further compared with 10% fat diet. In-
sulin resistance and hyperinsulinemia are implicated by higher blood glu-
cose levels (non-fasted) and area under the curve (AUC) in a glucose tol-
erance test (fasted), as well as higher plasma insulin levels, in ob/ob mice 
compared with ob/+ and +/+. A 45% fat diet further increased glucose, but 
not insulin levels. An alternative hypothesis implicates inflammation. The 
proinflammatory cytokine tumor necrosis factor (TNF)α was increased 
in ob/ob versus ob/+ and +/+, but was not further increased by a 45% fat 
diet. To draw firm conclusions for the cytokines interleukin 6 (IL-6) and 
IL-1β the positive samples were too few and none, respectively. The gen-
otypes ob/+ and +/+ did not differ significantly in any of these end points.
Conclusion: Both genetic and diet-induced obesity increases intestinal 
tumorigenesis in this mouse model, and the association between obesity 
and intestinal tumorigenesis may involve disturbed blood glucose regula-
tion and inflammation.
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Introduction: We examined whether perfluorooctanoate (PFOA) or per-
fluorooctane sulfonate (PFOS) had obesogenic effect or increased spon-
taneous intestinal tumorigenesis in the mouse model C57BL/6J-ApcMin 
(adenomatous polyposis coli-multiple intestinal neoplasia)/+ after in ute-
ro exposure.
Methods: The dams were exposed to PFOA or PFOS (0.01, 0.1 or 3.0 
mg/kg bw/day) by p.o. gavage on GD1–17. The Min/+ and +/+ offspring 
were terminated at week 11 for examination of intestinal tumorigenesis or 
at week 20 for obesogenic effect, respectively. Body weights of the dams 
and pups were recorded throughout life. Food intake was determined at 
week 6 and 10. Blood glucose (non-fasted) was measured at week 6 and 
11.
Results: No obesogenic effect of PFOA or PFOS was observed up to 20 
weeks of age. PFOA or PFOS did not increase the incidence or number of 
tumors in the small intestine or colon of Min/+ mice or affect their loca-
tion along the intestines. Feed intake was not affected. Some indications 
of toxicity of PFOA, but not of PFOS, were observed. There was lower 
survival of pups after 3.0 mg/kg PFOA, lower body weight in pups after 
3.0 and possibly 0.1 mg/kg PFOA, and increased relative liver weight 
after 0.01 and possibly 0.1 mg/kg PFOA. Plasma glucose was lower after 
0.01 and 0.1 mg/kg PFOA.
Conclusion: In utero exposure to PFOA and PFOS in the doses used did 
not have obesogenic effect on Min/+ or +/+ mice, at least not up to 11 or 
20 weeks of age, nor increased intestinal tumorigenesis in Min/+ mice.
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Introduction: We studied effects of 45% fat diet in various periods of life 
on development of obesity and susceptibility to intestinal tumorigenesis 
in the C57BL/6J-ApcMin (adenomatous polyposis coli-multiple intestinal 
neoplasia)/+ mice as adults.
Methods: The mice were exposed to 10% fat diet throughout life (nega-
tive control) or 45% fat diet in utero, during nursing, during both in utero 
and nursing, during adult life, or during their whole life-span, and termi-
nated at 11 weeks for tumorigenesis (Min/+) or 23 weeks for obesogenic 
effect (+/+).
Results: Body weight as area under the curve (AUC) from day 3 to ter-
mination was significantly increased after 45% fat diet during nursing, 
and during in utero and nursing, as well as throughout life. In the glucose 
tolerance test, early exposure to 45% fat diet in utero, during nursing, or 
during in utero and nursing, did not affect blood glucose, whereas expo-
sure to 45% fat diet as adults or throughout life significantly increased 
glucose AUC compared with the control. However, 45% fat diet during 
nursing, or during in utero and nursing, significantly increased the num-
ber of small intestinal tumors compared with the control. So did exposure 
to 45% fat diet in adult life or throughout life, but these dietary exposures 
for longer time did not significantly increase the number of small intesti-
nal tumors further compared with exposure during in utero and nursing.
Conclusion: A high fat diet early in life increases obesity and intestinal 
tumors in mice as adults, revealing a critical window of exposure.
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